Cermaq Mainstream is now owned 60% by the Norwegian government and hence the Norwegian public. Why are the Norwegian public exporting their diseases, environmental damage and sea lice problems around the world?
"Cermaq, 59.2 percent owned by the Norwegian state, said its second-quarter operating profit before adjustment for the value of fish stocks leapt to 229 million crowns from 60 million in the same period last year.
However, that was below analysts' average forecast of 262 million. Valderhaug said that while business was good in Norway and Canada, the company made a loss in Chile, in part because of losses to fish stocks there due to sea lice."
See: http://in.reuters.com/article/2013/08/27/cermaq-results-salmon-idINL6N0GS1JB20130827.
Cermaq lost 15% of their Chilean stock to death by sealice. Meanwhile the Norwegian derivative companies are still putting out papers saying that sea lice don't kill salmon. In BC, Canada see the recent paper by Marty, Saksida et al on sea lice in the Broughton Archipelago.
So the Norwegians are affirming and denying sea lice effects in different countries around the world at the same time. Such contradictions are common.
Cermaq share price is: 101.0 Norwegian Kronen, and they plan to return to shareholders a total dividend of 4.5 to 5.0 billion crowns.
Shortly, I will be putting the stats together to show that fish farms are a net negative to the BC economy. This loss of 15% of farmed salmon in Chile can be rendered into an estimated dollar value in BC by multiplying: Millions of BC farmed salmon X .15 X $30 per salmon. The last value is the CFIA fee for a disease-infected salmon that is destroyed.
No comments:
Post a Comment